Related Experiment Video
Updated: Dec 11, 2025

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
Published on: November 14, 2014
Docking Simulation and Sandwich Assay for Aptamer-Based Botulinum Neurotoxin Type C Detection
In-Hwan Oh1, Dae-Young Park1, Ji-Man Cha1
1School of Biological Sciences, Chungbuk National University, 1 Chungdae-Ro, Seowon-Gu, Cheongju 28644, Korea.
Researchers screened aptamers for binding to Botulinum toxin type C (BoNT/C). Molecular docking simulations identified optimal aptamers, enabling sensitive detection of BoNT/C using a sandwich assay.
Area of Science:
- Biotechnology
- Molecular Biology
- Biochemistry
Background:
- Aptamers are crucial in diagnostics and medicine due to their specific molecular binding.
- Experimental determination of aptamer-target binding structures is challenging.
- Computer-driven docking simulations aid in predicting molecular interactions.
Purpose of the Study:
- To screen and select aptamers with high binding affinity for Botulinum toxin type C (BoNT/C).
- To evaluate the utility of molecular docking simulations in aptamer selection.
- To develop a sensitive detection method for BoNT/C using selected aptamers.
Main Methods:
- Systematic evolution of ligands by exponential enrichment (SELEX) for aptamer screening.
- Surface plasmon resonance (SPR) for binding affinity analysis.
- Molecular operating environment (MOE) docking simulations for binding model evaluation.
Main Results:
- A pair of aptamers with high binding affinity to BoNT/C were identified.
- Docking simulations confirmed aptamers binding to distinct sites on BoNT/C.
- A sandwich assay utilizing the selected aptamers detected BoNT/C at concentrations as low as ~0.2 ng mL⁻¹.
Conclusions:
- Molecular docking simulations are effective for screening and selecting aptamers against specific targets.
- The identified aptamer pair enables sensitive detection of BoNT/C.
- This approach offers a valuable strategy for developing aptamer-based diagnostics.
More Related Videos
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014